Skip to content

BIOCARTIS

Active
Public limited companyfounded 201016 yrs activeGeneraal De Wittelaan 11B, 2800 Mechelen, BelgiumKBO/BCE: BE 0827.475.227

BIOCARTIS has been active since 2010 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €37.19M and a net result of €-22.92M. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 55% of 631 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Watch
Print / PDF

Checked score

Score 2025
62 / 100
Healthy
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability0=
Solvency85▼-13
Growth71▼-1
Track record100
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €2M at 30 days acceptable
Liquidity ample (current ratio 2.32 against 2.61 in 2024; short-term debt: 27.4% and cash: 9.8% of total assets), and 39.8% of the assets are financed with debt.
How do we compute the score and the probability?
Credit advice for your own amount and term

Signals

Eight signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 72
Relative position
BE, all sectors
reference
Sector 72
lower
← fewer bankruptcies more bankruptcies →
lowers risk · Lower-risk legal form
Companies with this legal form statistically fail less often than a BV.
KBO · legal form
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
60.2%
Return on assets
-37.1%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 16 years 0 20 y
raises risk · Persistent losses
Two consecutive loss-making years (2024 and 2025); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2025
Net result per financial year
182122232425
2018 to 2025 · latest year €-22.92M
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 08-06-2026, 53 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
53 d early
2024
77 d early
2023
22 d early
2022
70 d early
2021
75 d early
2020
47 d early
2019
77 d early
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
16-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, full schema

Turnover
€48.22M▲ 4.5%
2024 · €46.16M
2018: €28.49M 2021: €42.96M 2022: €50.31M 2023: €51.73M 2024: €46.16M
2018 → 2025
EBIT margin
-45.6%▲ 17.8pp
2024 · -63.4%
2018: -181.9% 2021: -169.4% 2022: -113.3% 2023: -104.9% 2024: -63.4%
2018 → 2025
Net result
€-22.92M▲ 25.5%
2024 · €-30.76M
2018: €-53.88M 2021: €-72.78M 2022: €-56.80M 2023: €-58.02M 2024: €-30.76M
2018 → 2025
Working capital
€22.41M▼ 23.6%
2024 · €29.36M
2018: €-186.38M 2021: €-56.24M 2022: €5.13M 2023: €-38.15M 2024: €29.36M
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Turnover€42.96M-€50.31M▲ 17.1%€51.73M▲ 2.8%€46.16M▼ 10.8%€48.22M▲ 4.5%
Equity€-5.75M-€45.75M€-12.46M€51.03M€37.19M▼ 27.1%
Operating result€-72.77M-€-57.02M▲ 21.6%€-54.27M▲ 4.8%€-29.27M▲ 46.1%€-21.98M▲ 24.9%
Net result€-72.78M-€-56.80M▲ 22.0%€-58.02M▼ 2.2%€-30.76M▲ 47.0%€-22.92M▲ 25.5%
Result per fiscal year
Operating resultNet result
€-80.00M€-60.00M€-40.00M€-20.00M€0Operating result 2021: €-72.77M€-72.77MNet result 2021: €-72.78M€-72.78MOperating result 2022: €-57.02M€-57.02MNet result 2022: €-56.80M€-56.80MOperating result 2023: €-54.27M€-54.27MNet result 2023: €-58.02M€-58.02MOperating result 2024: €-29.27M€-29.27MNet result 2024: €-30.76M€-30.76MOperating result 2025: €-21.98M€-21.98MNet result 2025: €-22.92M€-22.92M20212022202320242025
The operating result stays negative: a loss of €21.98M in 2025 against €29.27M in 2024; the loss shrinks.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €61.76M
Fixed assets €22.42M▼ 0.9%
Current assets €39.34M▼ 17.2%
Equity and liabilities €61.76M
Equity €37.19M▼ 27.1%
Debt €24.57M▲ 28.5%
The debt ratio rises from 27.3% to 39.8%. Equity is lower and debt is higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€-17.55M▲
2024 · €-19.70M
Cash flow
€-18.49M▲
2024 · €-21.19M
Solvency
60.2%▼
2024 · 72.7%
Current ratio
2.32▼
2024 · 2.61
Quick ratio
1.72▼
2024 · 1.84
Debt / equity
0.66▲
2024 · 0.37
ROE
-61.6%▼
2024 · -60.3%
ROA
-37.1%▲
2024 · -43.8%
Interest coverage
-24.32▼
2024 · -8.93
Debt
€24.57M▲
2024 · €19.13M
Debt ≤ 1 year
€16.93M▼
2024 · €18.18M
Debt > 1 year
€6.53M
Income taxes
€228k▲
2024 · €-60k
Staff costs
€31.68M▼
2024 · €33.06M
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€70.16M€61.76M▼
Fixed assets21/28€22.62M€22.42M▼
Intangible fixed assets21€3.58M€3.00M▼
Tangible fixed assets22/27€15.14M€14.40M▼
Plant, machinery and equipment23€8.69M€8.92M▲
Furniture and vehicles24€107k€73k▼
Leasing and similar rights25€6.19M€5.37M▼
Other tangible fixed assets26€90k€31k▼
Assets under construction and advance payments27€54k€14k▼
Financial fixed assets28€3.90M€5.01M▲
Affiliated companies280/1€2.04M€3.16M▲
Participating interests280€2.04M€3.16M▲
Other financial fixed assets284/8€1.86M€1.86M=
Shares284€1.14M€1.14M=
Amounts receivable and cash guarantees285/8€718k€718k=
Current assets29/58€47.54M€39.34M▼
Amounts receivable after more than one year29€1.52M€959k▼
Other amounts receivable291€1.52M€959k▼
Stocks and contracts in progress3€14.02M€10.29M▼
Stocks30/36€14.02M€10.29M▼
Raw materials and consumables30/31€5.09M€4.67M▼
Work in progress32€356k€483k▲
Finished goods33€8.58M€5.15M▼
Amounts receivable within one year40/41€21.26M€19.55M▼
Trade receivables40€19.28M€17.47M▼
Other amounts receivable41€1.99M€2.08M▲
Cash at bank and in hand54/58€8.09M€6.05M▼
Deferred charges and accrued income490/1€2.64M€2.48M▼
Equity and liabilities
Total equity and liabilities10/49€70.16M€61.76M▼
Equity10/15€51.03M€37.19M▼
Contributions10/11€81.37M€90.37M▲
Capital10€81.37M€90.37M▲
Issued capital100€81.37M€90.37M▲
Profit (loss) carried forward14€-30.65M€-53.57M▼
Investment grants15€319k€399k▲
Amounts payable17/49€19.13M€24.57M▲
Amounts payable after more than one year17-€6.53M
Financial debts170/4-€6.53M
Credit institutions173-€6.53M
Amounts payable within one year42/48€18.18M€16.93M▼
Financial debts43€2.50M-
Credit institutions430/8€2.50M-
Trade debts44€9.47M€9.25M▼
Suppliers440/4€9.47M€9.25M▼
Taxes, remuneration and social security45€5.92M€5.38M▼
Taxes450/3€113k€429k▲
Remuneration and social security454/9€5.81M€4.95M▼
Other amounts payable47/48€296k€2.29M▲
Accrued charges and deferred income492/3€945k€1.12M▲
Income statement Code20242025
Operating income70/76A€48.15M€51.51M▲
Turnover70€46.16M€48.22M▲
Change in stocks of work in progress, finished goods and contracts in progress71€-2.07M€-877k▲
Other operating income74€2.29M€3.99M▲
Non-recurring operating income76A€1.77M€173k▼
Operating charges60/66A€77.42M€73.49M▼
Goods for resale, raw materials and consumables60€10.39M€9.25M▼
Purchases600/8€10.01M€8.82M▼
Change in stocks: decrease (increase)609€385k€423k▲
Services and other goods61€27.02M€27.33M▲
Remuneration, social security and pensions62€33.06M€31.68M▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€9.57M€4.43M▼
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€-2.89M€1.51M▲
Provisions for liabilities and charges: additions (uses and reversals)635/8-€-1.46M
Other operating charges640/8€262k€295k▲
Non-recurring operating charges66A-€449k
Operating profit (loss)9901€-29.27M€-21.98M▲
Financial income75/76B€978k€480k▼
Recurring financial income75€978k€480k▼
Other financial income752/9€978k€480k▼
Financial charges65/66B€2.53M€1.20M▼
Recurring financial charges65€2.53M€1.20M▼
Debt charges650€2.21M€722k▼
Other financial charges652/9€322k€474k▲
Profit (loss) for the period before taxes9903€-30.82M€-22.69M▲
Income taxes67/77€-60k€228k▲
Taxes670/3€8k€228k▲
Tax adjustments and reversals of tax provisions77€67k-
Profit (loss) for the period9904€-30.76M€-22.92M▲
Profit (loss) for the period to be appropriated9905€-30.76M€-22.92M▲
Appropriation of the result
Profit (loss) to be appropriated9906€-88.78M€-53.57M▲
Profit (loss) brought forward from the previous period14P€-58.02M€-30.65M▲
Transfer from equity791/2€58.12M-
From contributions791€58.12M-
Social balance
Average headcount (FTE)9087227.8205.6▼

The notes to these accounts (73 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
07-07
State Gazette act Resignations & appointments
General meeting · Board meeting · Auditor appointment7 facts ▸
  • General meeting, 08/05/2026
  • Board meeting, 05/06/2026
  • Auditor appointment, Deloitte Bedrijfsrevisoren BV / Réviseurs d'Entreprise SRL (commissaris)
  • Director resignation, Christophe Carrein (bestuurder)
  • Power of attorney, Jan Leroy
  • Power of attorney, Stefanie Van den Bosch
  • Power of attorney, Biocartis NV
08-06
NBB filing Annual accounts filed
fiscal year 2025 · full schema
2025
29-12
State Gazette act Resignations & appointments
General meeting · Auditor appointment · Permanent representative3 facts ▸
  • General meeting, 08/10/2025
  • Auditor appointment, Deloitte Bedrijfsrevisoren BV (commissaris)
  • Permanent representative, Koen Neijens
04-11
State Gazette act Resignations & appointments
Board meeting · Power of attorney7 facts ▸
  • Board meeting, 02/10/2025
  • Power of attorney, Benoit de Voghel
  • Power of attorney, Hilde Verduyckt
  • Power of attorney, Stefanie Van den Bosch
  • Power of attorney, Stijn Dewinter
  • Power of attorney, Christophe Carrein
  • Power of attorney, Randy Brian Polonsky
22-09
State Gazette act Capital & shares · Statutes amendment
General meeting · Capital increase · Capital4 facts ▸
  • General meeting, 16 september 2025
  • Capital increase, €5.000.000
  • Capital, €90.365.118
  • Statutes amendment
27-06
State Gazette act Capital & shares · Statutes amendment
General meeting · Capital increase · Capital3 facts ▸
  • General meeting, 24 juni 2025
  • Capital increase, €4.000.000
  • Capital, €85.365.118
15-05
NBB filing Annual accounts filed
fiscal year 2024 · full schema
2024
31-12
Financial Liquidity quadruplescurrent ratio 2.61
Current ratio from 0.64 to 2.61; short-term debt falls from €105.39M to €18.18M.
31-12
Financial Equity above €50MEq €51.03M
Equity rises from €-12.46M to €51.03M.
13-12
State Gazette act Resignations & appointments
General meeting · Board meeting · Director resignation21 facts ▸
  • General meeting, 15/11/2024
  • Board meeting, 19/11/2024
  • Director resignation, George Anthony Cardoza (bestuurder)
  • Director appointment, Randy Brian Polonsky (bestuurder)
  • Mandate compensation, Randy Brian Polonsky
  • Power of attorney, George Anthony Cardoza
  • Power of attorney, Erik Vossenaar
  • Power of attorney, Randy Brian Polonsky
  • Power of attorney, Barbara Nagy
  • Power of attorney, John Roger Moody Jr.
  • Power of attorney, Sarah Baudenelle
  • Power of attorney, Nane Vercammen
  • +9 further facts in this act
26-09
State Gazette act Miscellaneous
Permanent representative2 facts ▸
  • Permanent representative, Koen Neijens (vaste vertegenwoordiger)
  • Permanent representative, Nico Houthaeve (vaste vertegenwoordiger)
23-08
State Gazette act Capital & shares · Statutes amendment
General meeting · Capital increase · Capital4 facts ▸
  • General meeting, 14 augustus 2024
  • Capital increase, €16.000.000
  • Capital, €81.365.118
  • Power of attorney, Virginie Vandercruyssen
08-08
State Gazette act Miscellaneous
Board meeting · Power of attorney8 facts ▸
  • Board meeting, 23/07/2024
  • Power of attorney, Marnik De Troyer
  • Power of attorney, Nane Vercammen
  • Power of attorney, Sarah Baudenelle
  • Power of attorney, Roger Moody
  • Power of attorney, George Cardoza
  • Power of attorney, Erik Vossenaar
  • Power of attorney, David Dejans
09-07
NBB filing Annual accounts filed
fiscal year 2023 · full schema
04-03
State Gazette act Capital & shares · Statutes amendment · Miscellaneous
General meeting · Capital increase · Capital decrease7 facts ▸
  • General meeting, 29 februari 2024
  • Capital increase, €78.435.081,37
  • Capital decrease, €58.122.507,37
  • Capital, €65.365.118
  • Statutes amendment
  • Board meeting, 6 februari 2024
  • Power of attorney, Sean O’Dowd
05-01
State Gazette act Resignations & appointments · Miscellaneous
Board meeting · Director resignation · Power of attorney21 facts ▸
  • Board meeting, 28 december 2023
  • Director resignation, Roger Moody (CEO)
  • Power of attorney, Roger Moody
  • Director resignation, George Cardoza (CFO en Hoofd Service Delivery)
  • Power of attorney, George Cardoza
  • Power of attorney, Karlien Hermans
  • Director appointment, Sarah Baudenelle (dagelijks bestuurder)
  • Power of attorney, Sarah Baudenelle
  • Power of attorney, Sarah Baudenelle
  • Power of attorney, Roger Moody
  • Power of attorney, George Cardoza
  • Power of attorney, Erik Vossenaar
  • +9 further facts in this act
2023
29-08
State Gazette act Resignations & appointments
General meeting · Board meeting · Director resignation16 facts ▸
  • General meeting, 03/08/2023
  • Board meeting, 08/08/2023
  • Director resignation, Scmiles BV (bestuurder)
  • Director appointment, George Anthony Cardoza (bestuurder)
  • Mandate compensation, George Anthony Cardoza
  • Director resignation, Marcofin BV (CFO)
  • Director resignation, Scmiles BV (COO)
  • Power of attorney, George Anthony Cardoza (CFO en Head of Service Delivery)
  • Power of attorney, John Roger Moody Jr. (bankbevoegdheden)
  • Power of attorney, George Anthony Cardoza (bankbevoegdheden)
  • Power of attorney, David Dejans (bankbevoegdheden)
  • Power of attorney, Marnik De Troyer (bankbevoegdheden)
  • +4 further facts in this act
01-06
State Gazette act Resignations & appointments
General meeting · Board meeting · Director resignation17 facts ▸
  • General meeting, 19/04/2023
  • Board meeting, 19/04/2023
  • Director resignation, South Bay Ventures (SBV) BV (bestuurder)
  • Director resignation, South Bay Ventures (SBV) BV (gedelegeerd bestuurder)
  • Director appointment, Roger Moody (bestuurder)
  • Mandate compensation, Roger Moody
  • Director appointment, Roger Moody (gedelegeerd bestuurder)
  • Power of attorney, Roger Moody
  • Power of attorney, Roger Moody
  • Power of attorney, Marcofin BV
  • Power of attorney, Scmiles BV
  • Power of attorney, Marnik De Troyer
  • +5 further facts in this act
22-05
NBB filing Annual accounts filed
fiscal year 2022 · full schema
19-05
State Gazette act Capital & shares · Statutes amendment
General meeting · Capital decrease · Capital3 facts ▸
  • General meeting, 15 mei 2023
  • Capital decrease, €56.795.562
  • Capital, €45.052.544
2022
31-12
Financial Equity above €25MEq €45.75M
Equity rises from €-5.75M to €45.75M.
07-06
State Gazette act Capital & shares
Sole-shareholder declaration · Permanent representative2 facts ▸
  • Sole-shareholder declaration, All shares consolidated in one hand; SBV BV identified as the sole shareholder.
  • Permanent representative, Herman Verrelst
07-06
State Gazette act Resignations & appointments
Shareholder resolution · Auditor appointment · Permanent representative6 facts ▸
  • Shareholder resolution, 13/05/2022
  • Auditor appointment, Deloitte Bedrijfsrevisoren BV (commissaris)
  • Permanent representative, Nico Houthaeve
  • Board resolution, 23/05/2022
  • Power of attorney, Susan (Sue) Werner
  • Ratification, alle handelingen ... voor zover deze in overeenstemming zijn met de hierboven toegekende bijzondere bevoegdheden, 02/05/2022
25-05
State Gazette act Capital & shares · Statutes amendment
General meeting · Capital increase · Capital decrease4 facts ▸
  • General meeting, 16 mei 2022
  • Capital increase, €108.491.766,67
  • Capital decrease, €72.780.320,67
  • Capital, €101.848.106
17-05
NBB filing Annual accounts filed
fiscal year 2021 · full schema
04-04
State Gazette act Resignations & appointments
General meeting · Board meeting · Director resignation16 facts ▸
  • General meeting, 18/03/2022
  • Board meeting, 22/03/2022
  • Director resignation, Herman Verrelst (bestuurder)
  • Director appointment, South Bay Ventures (SBV) BV (bestuurder)
  • Permanent representative, Herman Verrelst
  • Director resignation, Herman Verrelst (gedelegeerd bestuurder)
  • Director appointment, South Bay Ventures (SBV) BV (gedelegeerd bestuurder)
  • Power of attorney, South Bay Ventures (SBV) BV
  • Power of attorney, Herman Verrelst
  • Power of attorney, South Bay Ventures (SBV) BV
  • Power of attorney, Marcofin BV
  • Permanent representative, Jean-Marc Roelandt
  • +4 further facts in this act
2021
31-12
Financial Weakest financial yearnet €-72.78M
Net result drops to €-72.78M, the lowest in the series; recovery starts the following year.
09-11
State Gazette act Resignations & appointments
Board meeting · Power of attorney3 facts ▸
  • Board meeting, 25/10/2021
  • Power of attorney, Jeroen Senaeve
  • Power of attorney, Karlien Hermans
14-06
NBB filing Annual accounts filed
fiscal year 2020 · full schema
07-06
State Gazette act Capital & shares
General meeting · Capital decrease · Capital3 facts ▸
  • General meeting, 14 mei 2021
  • Capital decrease, €59.508.369
  • Capital, €66.136.660
25-03
State Gazette act Resignations & appointments
General meeting · Permanent representative3 facts ▸
  • General meeting, 08/05/2020
  • Permanent representative, Gert Vanhees
  • Permanent representative, Nico Houthaeve
26-01
State Gazette act Resignations & appointments
Board meeting · Power of attorney3 facts ▸
  • Board meeting, 2021-01-08
  • Power of attorney, Marijke De Wit
  • Power of attorney, Jeroen Senaeve
2020
26-05
State Gazette act Resignations & appointments
Board meeting · Power of attorney · Permanent representative12 facts ▸
  • Board meeting, 24/04/2020
  • Board meeting, 12/05/2020
  • Power of attorney, Scmiles BV
  • Power of attorney, Marcofin BV
  • Permanent representative, Petrus Houwen
  • Permanent representative, Jean-Marc Roelandt
  • Power of attorney, Herman Verrelst
  • Power of attorney, Marcofin BV
  • Power of attorney, Scmiles BV
  • Power of attorney, Marnik De Troyer
  • Power of attorney, Biocartis
  • Ratification, alle handelingen die Marcofin BV, vast vertegenwoordigd door Jean-Marc Roelandt, zou hebben gesteld ... voor zover deze in overeenstemming zijn met de hierboven…
15-05
NBB filing Annual accounts filed
fiscal year 2019 · full schema
14-05
State Gazette act Capital & shares
General meeting · Capital decrease · Capital7 facts ▸
  • General meeting, 8 mei 2020
  • Capital decrease, €61.125.498
  • Capital, €125.645.029
  • Statutes amendment
  • Statutes amendment
  • Corporate purpose, De vennootschap heeft tot voorwerp zowel in België als in het buitenland zowel voor eigen naam en voor eigen rekening als voor naam of voor rekening van derden,…
  • Power of attorney, VANDORPE Tim, Wouter
22-04
State Gazette act Resignations & appointments
Board meeting · Power of attorney · Permanent representative6 facts ▸
  • Board meeting, 31/03/2020
  • Power of attorney, Ewoud Welten
  • Power of attorney, Herman Verreist
  • Power of attorney, Scmiles BV
  • Power of attorney, Marnik De Troyer
  • Permanent representative, Petrus Houwen
03-01
State Gazette act Capital & shares · Statutes amendment
General meeting · Capital increase · Capital decrease7 facts ▸
  • General meeting, 18/12/2019
  • Capital increase, €300.285.261,09
  • Capital decrease, €113.576.234,09
  • Share issue, herindeling van aandelen
  • Capital, €186.770.527
  • Statutes amendment
  • Permanent representative, Gert VANHEES
2019
05-12
State Gazette act Resignations & appointments
Board meeting · Power of attorney · Permanent representative15 facts ▸
  • Board meeting, 08/11/2019
  • Power of attorney, WA2T BVBA
  • Power of attorney, Marijke De Wit
  • Power of attorney, Passport Regulatory Consulting LLC
  • Power of attorney, Carole Harris
  • Power of attorney, Susy Spruyt
  • Power of attorney, Susy Spruyt
  • Power of attorney
  • Power of attorney, Herman Verrelst
  • Power of attorney, Ewoud Welten
  • Power of attorney, Scmiles BVBA
  • Power of attorney, Manik De Troyer
  • +3 further facts in this act
08-07
State Gazette act Resignations & appointments
Shareholder decision · Auditor appointment · Permanent representative3 facts ▸
  • Shareholder decision, 14/06/2019
  • Auditor appointment, Deloitte Bedrijfsrevisoren BV CVBA (commissaris)
  • Permanent representative, Gert Vanhees
27-06
NBB filing Annual accounts filed
fiscal year 2018 · full schema
24-05
State Gazette act Resignations & appointments
General meeting · Board meeting · Director resignation8 facts ▸
  • General meeting, 30/04/2019
  • Board meeting, 07/05/2019
  • Director resignation, Citros vof (bestuurder)
  • Director appointment, SCMILES BVBA (bestuurder)
  • Mandate compensation, SCMILES BVBA
  • Power of attorney, SCMILES BVBA
  • Power of attorney, Citros vof
  • Director appointment, SCMILES BVBA (chief operating officer)
2018
04-10
State Gazette act Resignations & appointments
Director resignation · Permanent representative · Director appointment5 facts ▸
  • Director resignation, WA2T BVBA (bestuurder)
  • Permanent representative, Chris Heymans
  • Director appointment, Herman Verrelst (bestuurder)
  • Director appointment, Citros vof (bestuurder)
  • Permanent representative, Hilde Eylenbosch
11-06
NBB filing Annual accounts filed
fiscal year 2017 · full schema
25-04
State Gazette act Miscellaneous
General meeting1 fact ▸
  • General meeting, 27/02/2018
2017
22-11
State Gazette act Resignations & appointments
General meeting · Board meeting · Director resignation15 facts ▸
  • General meeting, 31/08/2017
  • Board meeting, 05/09/2017
  • Director resignation, Hilde Windels BVBA (bestuurder)
  • Director resignation, Hilde Windels BVBA (gedelegeerd bestuurder)
  • Director appointment, Herman Verrelst (bestuurder)
  • Mandate compensation, Herman Verrelst
  • Director appointment, Herman Verrelst (gedelegeerd bestuurder)
  • Power of attorney, Herman Verrelst
  • Power-of-attorney revocation, Ewoud Welten
  • Power of attorney, Ewoud Welten
  • Power of attorney, Marnik De Troyer
  • Power of attorney, Herman Verrelst
  • +3 further facts in this act
27-06
State Gazette act Miscellaneous
General meeting1 fact ▸
  • General meeting, 09/06/2017
27-06
NBB filing Annual accounts filed
fiscal year 2016 · full schema
23-06
State Gazette act Capital & shares · Statutes amendment
General meeting · Capital decrease · Capital6 facts ▸
  • General meeting, 12/06/2017
  • Capital decrease, €51.755.161,77
  • Capital, €61.500
  • Statutes amendment
  • Power of attorney, VANDORPE Tim, Wouter
  • Power of attorney, Baker & McKenzie
26-04
State Gazette act Resignations & appointments
General meeting · Board meeting · Director resignation8 facts ▸
  • General meeting, 21/03/2017
  • Board meeting, 21/03/2017
  • Director resignation, Valetusan Ltd. (bestuurder)
  • Permanent representative, Rudi Pauwels
  • Director appointment, Citros vof (bestuurder)
  • Permanent representative, Hilde Eylenbosch
  • Mandate compensation, Citros vof
  • Power of attorney, Citros vof
2016
21-10
State Gazette act Resignations & appointments
Board meeting · Director reappointment · Permanent representative4 facts ▸
  • Board meeting, 14/09/2016
  • Director reappointment, Hilde Windels BVBA (gedelegeerd bestuurder)
  • Permanent representative, Hilde Windels
  • Power of attorney, Hilde Windels BVBA
02-08
State Gazette act Resignations & appointments
General meeting · Director appointment · Permanent representative6 facts ▸
  • General meeting, 10/06/2016
  • Director appointment, Valetusan Ltd. (bestuurder)
  • Permanent representative, Rudi Pauwels
  • Mandate compensation, Valetusan Ltd.
  • Auditor appointment, Deloitte Bedrijfsrevisoren (commissaris)
  • Permanent representative, Gert Vanhees
28-06
State Gazette act Capital & shares · Statutes amendment
General meeting · Capital decrease · Capital4 facts ▸
  • General meeting, 10/06/2016
  • Capital decrease, €77.244.838,23
  • Capital, €51.816.661,77
  • Statutes amendment
31-05
State Gazette act Resignations & appointments
Board meeting · Power of attorney3 facts ▸
  • Board meeting, 28/04/2016
  • Power of attorney, Passport Regulatory Consulting LLC
  • Power of attorney, Patrick Hofkens
2015
05-11
State Gazette act Resignations & appointments
General meeting · Director resignation · Power of attorney10 facts ▸
  • General meeting, 15/10/2015
  • Director resignation, Ismedrix Life Sciences BV (bestuurder)
  • Power of attorney, Ismedrix Life Sciences BV
  • Power of attorney, WA2T BVBA
  • Power of attorney, Susy Spruyt
  • Power of attorney, Ewoud Welten
  • Power of attorney, Patrick Hofkens
  • Power of attorney, Susy Spruyt
  • Power of attorney, Ewoud Welten
  • Power of attorney, Patrick Hofkens
2014
27-11
State Gazette act Resignations & appointments
General meeting · Director reappointment · Permanent representative9 facts ▸
  • General meeting, 13/06/2014
  • Director reappointment, Hilde Windels BVBA (bestuurder)
  • Permanent representative, Hilde Windels
  • General meeting, 01/07/2014
  • Director appointment, Ismedrix Life Sciences B.V. (bestuurder)
  • Permanent representative, Cornelis Adriaan Antonie (roepnaam Joris) Schuurmans
  • Board meeting, 01/07/2014
  • Power of attorney, Ismedrix Life Sciences B.V.
  • Director reappointment, Hilde Windels BVBA (gedelegeerd bestuurder)
05-08
State Gazette act Capital & shares
General meeting · Capital increase · Share issue4 facts ▸
  • General meeting, 30-06-2014
  • Capital increase, €109.000.000
  • Share issue, 17.723.577, 6,15
  • Statutes amendment
02-05
State Gazette act Purpose
General meeting · Purpose change · Power of attorney3 facts ▸
  • General meeting, 10-04-2014
  • Purpose change, De vennootschap heeft tot doel zowel in België als in het buitenland zowel voor eigen naam en voor eigen rekening als voor naam of voor rekening van derden, all…
  • Power of attorney, DE MEULENAERE Ann
02-01
State Gazette act Capital & shares
General meeting · Capital increase · Capital9 facts ▸
  • General meeting, 13 december 2013
  • Capital increase, €20.000.000
  • Capital, €20.061.500
  • Statutes amendment
  • Statutes amendment
  • Statutes amendment
  • Statutes amendment
  • Corporate purpose, De vennootschap heeft tot doel, in België en in het buitenland zowel voor eigen rekening als voor rekening van derden, alleen of in participatie met derden: a.…
  • Power of attorney, Ann DE MEULENAERE
2013
22-11
State Gazette act Resignations & appointments
Board meeting · Director resignation · Power of attorney4 facts ▸
  • Board meeting, 10 oktober 2013
  • Director resignation, Calexin BVBA (bestuurder)
  • Power of attorney, Calexin BVBA
  • Permanent representative, Inge Basteleurs
17-07
State Gazette act Resignations & appointments
Board meeting · Director resignation · Power of attorney3 facts ▸
  • Board meeting, 04/06/2013
  • Director resignation, Clark Harrison (bestuurder)
  • Power of attorney, Clark Harrison
21-05
State Gazette act Resignations & appointments
General meeting · Auditor appointment · Mandate compensation3 facts ▸
  • General meeting, 15/04/2013
  • Auditor appointment, Deloitte Bedrijfsrevisoren (Commissaris - Revisor)
  • Mandate compensation, Deloitte Bedrijfsrevisoren
30-04
State Gazette act Resignations & appointments
Board meeting · Director resignation · Power of attorney6 facts ▸
  • Board meeting, 08/04/2013
  • Director resignation, Gregory Parekh (bestuurder)
  • Power of attorney, Gregory Parekh
  • Director appointment, Hilde Windels BVBA (gedelegeerd bestuurder)
  • Permanent representative, Hilde Windels
  • Power of attorney, Hilde Windels BVBA
06-03
State Gazette act Resignations & appointments
General meeting · Director appointment · Permanent representative4 facts ▸
  • General meeting, 28/01/2013
  • Director appointment, Calexin BVBA (bestuurder)
  • Permanent representative, Inge Basteleurs
  • Mandate compensation, Calexin BVBA
05-02
State Gazette act Resignations & appointments
General meeting · Director resignation · Director appointment5 facts ▸
  • General meeting, 03/09/2012
  • Director resignation, Nader Donzel (bestuurder)
  • Director appointment, WA2T BVBA (bestuurder)
  • Permanent representative, Christian Heymans
  • Mandate compensation, WA2T BVBA
2012
26-11
State Gazette act Resignations & appointments
General meeting · Director appointment · Mandate compensation3 facts ▸
  • General meeting, 16/11/2011
  • Director appointment, Gregory Parekh (bestuurder)
  • Mandate compensation, Gregory Parekh
26-11
State Gazette act Resignations & appointments
General meeting · Director appointment · Mandate compensation3 facts ▸
  • General meeting, 5 december 2011
  • Director appointment, Clark Harrison (bestuurder)
  • Mandate compensation, Clark Harrison
26-11
State Gazette act Resignations & appointments
Board meeting · Power of attorney6 facts ▸
  • Board meeting, 01/08/2012
  • Power of attorney, Hilde Windels BVBA
  • Power of attorney, Gregory Parekh
  • Power of attorney, Gregory Parekh
  • Power of attorney, Hilde Windels BVBA
  • Power of attorney, Clark Harrison
2011
07-09
State Gazette act Resignations & appointments
General meeting · Board meeting · Director appointment13 facts ▸
  • General meeting, 30-06-2011
  • General meeting, 01-08-2011
  • Board meeting, 30-06-2011
  • Director appointment, Hilde Windels BVBA (bestuurder)
  • Permanent representative, Hilde Windels
  • Mandate compensation, Hilde Windels BVBA
  • Director appointment, Biovicca BVBA (bestuurder)
  • Permanent representative, Christophe Bourrilly
  • Mandate compensation, Biovicca BVBA
  • Director resignation, Biovicca BVBA (bestuurder)
  • Director resignation, Nader Donzel (gedelegeerd bestuurder)
  • Director appointment, Hilde Windels BVBA (gedelegeerd bestuurder)
  • +1 further facts in this act
27-04
State Gazette act Registered office
Board meeting · Registered-office move2 facts ▸
  • Board meeting, 13/04/2011
  • Registered-office move, Generaal De Wittelaan 11B, 2800 Mechelen
07-02
State Gazette act Resignations & appointments
Board meeting · Director appointment · Power of attorney3 facts ▸
  • Board meeting, 19/11/2010
  • Director appointment, Luc Lammens (dagselijks bestuurder)
  • Power of attorney, Luc Lammens
2010
13-07
State Gazette act Incorporation
Incorporation · Founding capital · Corporate purpose10 facts ▸
  • Incorporation, 01/07/2010
  • Founding capital, €61.500
  • Corporate purpose, a. het onderzoeken en ontwikkelen van alle producten en diensten gerelateerd aan micro- en nanotechnologie, met inbegrip van maar niet beperkt tot toepassingen…
  • Director appointment, Rudi Pauwels (bestuurder)
  • Director appointment, Nader Donzel (bestuurder)
  • Director appointment, Nader Donzel (gedelegeerd bestuurder)
  • First fiscal year, 31/12/2011, datum verkrijging rechtspersoonlijkheid
  • Registered office, 1000 Brussel, Barricadenplein 13
  • Legal form, Naamloze vennootschap
  • Duration, onbepaald
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
27 directors, no change since 2026
Randy Brian Polonsky
Director · since 02-11-2024
Current
Sarah Baudenelle
Dagelijks bestuurder · since 01-01-2024
Current
SCMILES BVBA
Director · since 08-04-2019 · Legal entity
Not recently confirmed
Valetusan Ltd
Director · since 10-06-2016 · Foreign entity · perm. rep.: Rudi Pauwels
Not recently confirmed
Ismedrix Life Sciences B.V.
Director · since 01-07-2014 · Legal entity · perm. rep.: Cornelis Adriaan Antonie (roepnaam Joris) Schuurmans
Not recently confirmed
CALEXIN
Director · since 02-01-2013 · Private limited company · perm. rep.: Inge Basteleurs
Not recently confirmed
+ 2 not shown in this overview
18-03-2026 Christophe Carrein: Resigned as Director
02-11-2024 Randy Brian Polonsky: Appointed as Director
01-11-2024 George Anthony Cardoza: Resigned as Director
01-01-2024 Sarah Baudenelle: Appointed as Dagelijks bestuurder
31-12-2023 George Cardoza: Resigned as Cfo en hoofd service delivery
31-12-2023 Roger Moody: Resigned as Ceo
02-09-2023 George Anthony Cardoza: Appointed as Director
01-09-2023 Scmiles BV: Resigned as Coo
01-09-2023 Scmiles BV: Resigned as Director
04-08-2023 Marcofin BV: Resigned as Cfo
24-04-2023 Roger Moody: Appointed as Managing director
24-04-2023 Roger Moody: Appointed as Director
24-04-2023 South Bay Ventures (SBV) BV: Resigned as Director
24-04-2023 South Bay Ventures (SBV) BV: Resigned as Managing director
01-04-2022 South Bay Ventures (SBV) BV: Appointed as Managing director
01-04-2022 South Bay Ventures (SBV) BV: Appointed as Director
01-04-2022 Herman Verrelst: Resigned as Director
01-04-2022 Herman Verrelst: Resigned as Managing director
01-05-2019 SCMILES BVBA: Appointed as Director
30-04-2019 Citros vof: Resigned as Director
08-04-2019 SCMILES BVBA: Appointed as Chief operating officer
08-06-2018 Herman Verrelst: Appointed as Director
08-06-2018 Citros vof: Appointed as Director
08-06-2018 WA2T BVBA: Resigned as Director
+ 30 not shown in this overview
Location & real-estate footprint
Registered office, Mechelen · 1 establishment unit since 2010
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Generaal De Wittelaan 11B2800 Mechelen
Ground area
5,690 m²
Building footprint
2,739 m²
Volume, LiDAR
18,318 m³
Parcel 12402A0174/00M002, Flanders · tallest building 10.0 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Biocartis
Generaal De Wittelaan 11B, 2800 MechelenManufacture of medical and dental instruments and supplies
since 20102.190.977.206
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
12402A0174/00M002 Flanders 5,690 m² 1 · 2,739 m² 10.0 m · 2 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Statutory auditor

3 auditors
DELOITTE Bedrijfsrevisoren BVCurrent
Statutory auditor · represented by Nico Houthaeve
07-06-2022 → present
Show 2 earlier auditors
Deloitte bedrijfsrevisoren BV CVBA
Statutory auditor · represented by Gert Vanhees
succeeded by DELOITTE Bedrijfsrevisoren BV in 2022
08-07-2019 → 07-06-2022
Deloitte Bedrijfsrevisoren/Réviseurs d’Entreprises
Statutory auditor
succeeded by Deloitte bedrijfsrevisoren BV CVBA in 2019
21-05-2013 → 08-07-2019

Structure & network

Ownership & control

3 parties
Control over this companysits on this company's board3
CALEXIN
1 subsidiary · 1 location
WORKING ANYWHERE ANYTIME TOGETHER
1 subsidiary · 1 location
Valetusan Ltd
1 subsidiary
controls
BIOCARTISBE 0827.475.227

Capital and shareholders

Capital increase of 5,000,000 EUR
State Gazette act of 22-09-2025
Capital increase of 4,000,000 EUR
State Gazette act of 27-06-2025
Capital increase of 16,000,000 EUR · 16,000,000 new shares
State Gazette act of 23-08-2024
Capital increase of 78,435,081.37 EUR · 78,435,081 new shares
State Gazette act of 04-03-2024
Capital increase of 108,491,766.67 EUR
State Gazette act of 25-05-2022
Capital increase of 300,285,261.09 EUR
State Gazette act of 03-01-2020
Capital increase of 109,000,000 EUR
State Gazette act of 05-08-2014
Capital increase of 20,000,000 EUR
State Gazette act of 02-01-2014
Show 1 more events
Founding capital 61,500 EUR · 10,000 shares
State Gazette act of 13-07-2010

Public money · subsidies and aid

Flemish government

2022 to 2025 · 10 entries · 2,102,683 EUR awarded · 890,207 EUR paid
Year Entries awardedpaid
2025 3 2,035,685 EUR823,209 EUR
2024 2 23,297 EUR23,297 EUR
2023 2 -362,650 EUR21,965 EUR
2022 3 406,351 EUR21,736 EUR
Schemes
Ontwikkelingsproject
3 entries · 2,019,476 EUR · 807,000 EUR paid · Fonds voor Innoveren en Ondernemen
Vlaams opleidingsverlof (VOV)
4 entries · 46,204 EUR · 46,204 EUR paid · Departement Werk en Sociale Economie
Individueel Maatwerk
2 entries · 27,003 EUR · 27,003 EUR paid · Departement Werk en Sociale Economie
Werkbaarheidscheque (stopgezet)
1 entry · 10,000 EUR · 10,000 EUR paid · Departement Werk en Sociale Economie

European research

4 projects · 1 as coordinator · 838,186 EUR EU contribution
Programmes
fp7
2 entries · 705,946 EUR
h2020
2 entries · 132,240 EUR
Projects
Platform foR European Preparedness Against (Re-)emerging Epidemics
fp7 · participant · 01-02-2014 to 31-01-2021 · 470,946 EUR · PREPARE
Development of a fully automated, integrated solution that can support a wide range of complex sample preparation protocols
fp7 · coordinator · 01-01-2013 to 31-12-2014 · 235,000 EUR · SPCard
New Diagnostics for Infectious Diseases: “ND4ID”
h2020 · participant · 01-03-2016 to 29-02-2020 · 132,240 EUR · ND4ID
Additive Manufacturing of 3D Microfluidic MEMS for Lab-on-a-Chip applications
h2020 · participant · 01-01-2018 to 30-06-2022 · M3DLoC

Similar companies · same sector, comparable size

Biotalys
BE 0508.931.185
Gent · Eq €35.75M
Ardena Holding
BE 0633.855.309
Gent · Eq €33.35M
Confo Therapeutics
BE 0632.474.939
Gent · Eq €33.29M
Baxter R and D Europe
BE 0419.859.253
Lessines · Eq €30.51M
AUGUSTINE THERAPEUTICS
BE 0722.705.230
Leuven · Eq €28.98M
Of 760 companies in sector 72101 we hold annual accounts for 481. 68 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPublic limited company
Founded02-07-2010
Fiscal year end31-12
Activities, NACEBEL
72101Research and development on biotechnology
86901Human health activities
86910Medical imaging and medical laboratories
72109Other research and development on natural sciences
Sources
Crossroads Bank for EnterprisesNational Bank · 15 filingsAddress and cadastre registers

Data from official sources, last processed on 14-09-2026. Scores and ratios are computed by Checked and are not a credit decision.

Contact details

3 entries
Establishment Mechelen 2.190.977.206
E-mail:info@biocartis.com
Establishment Mechelen 2.190.977.206
Phone:015/632865
Establishment Mechelen 2.190.977.206

We would like to set cookies. That happens only with your consent. What we measure